Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 66% the number to beat...

<< Previous

Bullboard Posts

Next >>

Comment by floatinketuckyon Mar 26, 2022 1:04pm

189 Views

Post# 34548340

RE:RE:RE:66% the number to beat...

"similar to the safety and efficacy results(66%CR) observed in the phase 1b"

So they just need toppling data better than the competition.

At the time that was the only number out there. Now we know the mark the comp has thrown and

our true arrow is about to fly and land enough above the comp for market domination.

We do not have to beat 66 percent .. .there is no competion at that CR point. Except Theralase.